CEO Jeff Galvin joins HIV activist and Youtube creator Raif Derrazi to discuss the launch of Adimmune™ – a new HIV-focused spinoff company that will focus solely on advancing an HIV cure, building upon more than a decade of work by American Gene Technologies® (AGT™). Galvin provides insights on data from AGT’s HIV Phase I clinical trial, as well as why Addimmune was created to continue the HIV research.
